Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lianxia Ningxin Granules
- Development stage
- Phase 4
- Lead developer
- Beijing University of Chinese Medicine Third Affiliated Hospital
- Administration
- Oral
01
Overview
Lianxia Ningxin Granules (连夏宁心颗粒) is a traditional Chinese medicine (TCM) hospital preparation developed and used in China, primarily as an in-hospital formulation. It is designed for cardiovascular indications, with clinical research focused on its effects in conditions such as myocardial infarction and potentially other heart-related diseases. The granule formulation is based on the "Lianxia Ningxin" prescription, which typically combines multiple herbal ingredients to exert synergistic effects such as improving blood circulation, protecting cardiac tissue, and modulating inflammation or oxidative stress. The exact mechanism of action depends on the specific herbal components but generally involves multi-target modulation typical of TCM formulas[2][7].
- Brand names
- Lianxia Ningxin Granules
- Other names
- 连夏宁心颗粒
02
Targets
ADIPOQ (Adiponectin)ALB (Human serum albumin)CRH (Corticotropin-Releasing Factor)CXCL12 (C-X-C motif chemokine ligand 12)IL-6 (Interleukin 6)MAPK3 (Mitogen-activated protein kinase 1)NGF (Nerve growth factor)NOS3 (eNOS)NPPA (Atrial natriuretic peptide precursor)TGFB (GARP–latent transforming growth factor beta 1 complex)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on Lianxia Ningxin Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lianxia Ningxin Granules.